Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn)

**Product type:** Human Prescription Drug

**Active ingredient:** ATOLTIVIMAB; MAFTIVIMAB; ODESIVIMAB

**Strength:** 483.3; 483.3; 483.3 mg/14.5mL; mg/14.5mL; mg/14.5mL

**Dosage form:** Injection, Solution

**Route:** Intravenous

**Labeler:** Regeneron Pharmaceuticals, Inc.

**Marketing category:** BLA (BLA761169)